Abpro Holdings (ABPO) Current Taxes (2022 - 2025)
Abpro Holdings' (ABPO) quarterly Current Taxes came in at $4.4 million in Q3 2025, up 1101.93% YoY from $366161.0 in Q3 2024, and little changed on a QoQ basis from $4.4 million in Q2 2025.
Abpro Holdings (ABPO) Current Taxes (2022 - 2025) Analysis & Trends
Abpro Holdings (ABPO) has 4 years of Current Taxes data on file, last reported at $4.4 million in Q3 2025.
- Quarterly Current Taxes rose 1101.93% year-over-year to $4.4 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $4.4 million (up 1101.93% YoY) and the FY2024 annual result came in at $4.4 million, up 1328.0% from the prior year.
- Current Taxes was little changed at $4.4 million in Q3 2025, from $4.4 million in the prior quarter.
- In the past five years, Current Taxes ranged from a high of $4.4 million in Q4 2024 to a low of $6419.0 in Q2 2022.
- A 4-year average of $1.5 million and a median of $595076.0 in 2022 frame the typical range for Current Taxes.
- Annual changes were most pronounced in 2023 — Current Taxes jumped 28278.75% — and 2024, when it tumbled 81.91%.
- Tracing ABPO's Current Taxes over 4 years: stood at $823991.0 in 2022, then plunged by 62.6% to $308194.0 in 2023, then jumped by 1328.0% to $4.4 million in 2024, then changed by 0.0% to $4.4 million in 2025.
- The last three Current Taxes figures came in at $4.4 million (Q3 2025), $4.4 million (Q2 2025), and $366000.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.83 Bn | 130.98 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.79 Bn | 77.79 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.95 Bn | 59.77 Bn | 1.37 Bn | 49.00 Mn |
| 4 | Moderna | 58.59 Bn | 53.46 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.93 Bn | 36.83 Bn | 1.53 Bn | 76.32 Mn |
| 6 | Alnylam Pharmaceuticals | 31.52 Bn | 28.21 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 27.98 Bn | 9.58 Bn | 668.28 Mn | 76.36 Mn |
| 8 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | - |
| 10 | Abpro Holdings | 1.14 Mn | 1.14 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 4.40 Mn |
| Jun 30, 2025 | 4.40 Mn |
| Mar 31, 2025 | 366,000.00 |
| Dec 31, 2024 | 4.40 Mn |
| Sep 30, 2024 | 366,161.00 |
| Jun 30, 2024 | 338,507.00 |
| Mar 31, 2024 | 312,334.00 |
| Dec 31, 2023 | 308,194.00 |
| Sep 30, 2023 | 2.02 Mn |
| Jun 30, 2023 | 1.82 Mn |
| Mar 31, 2023 | 1.50 Mn |
| Dec 31, 2022 | 823,991.00 |
| Sep 30, 2022 | 293,453.00 |
| Jun 30, 2022 | 6,419.00 |